Lansoprazole Delayed-release Orally Disintegrating Tablets, 15 mg (Eccba344 1050 416e B6bc 12d9081562d0 04)
Lansoprazole Tablet, Orally Disintegrating
Product Images NDC 70771-1132
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 70771-1132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lansoprazole Delayed-release Orally Disintegrating Tablets, 30 mg (Eccba344 1050 416e B6bc 12d9081562d0 05)
This is a description of a medication named Lansoprazole which is available in the form of delayed-release orally disintegrating tablets. It is used for treating acid-related disorders. The packaging contains 100 tablets segregated into 10x10 unit doses. It is recommended to keep the medication at a Controlled Room Temperature. The medication should be kept away from the reach of children. The patient is advised to not chew or crush the tablets and just put it on their tongue to swallow. In case of children or adults who have difficulty in swallowing, the tablet can be administered via an oral syringe.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
